While small caps usually lead the way out of recession, don't expect Hi Ho to do so, this year. -It will remain on the CNSX, -Moly price, while recuperating somewhat ($9.25), is far off its constant over $30 of last year. -Even the CEO has other interests.

HHS is dormant, for now, imo, and would need extraordinary news for any real move. Although not diluted, HHS is far from the good $2.00-a-share days.

Trading both here and in Germany is minimal.

Skip or watch from afar.

go